Stacey Chang-Douglass

Head of Health Economics

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stacey Chang-Douglass is the Head of Health Economics at Clarivate, based in the United States. Her research focuses on health economics, particularly in relation to cost-effectiveness analyses, general population utility adjustments, and health technology assessments. Recent articles include evaluations of treatment options for alpha-mannosidosis and insights into NICE's early value assessment pilot project.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Gabriel Rogers

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stacey Chang-Douglass

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Letter to the Editor concerning ‘cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’

EE309 Cost-Effectiveness Analysis of Velmanase Alfa in Patients with Alpha Mannosidosis from a UK Health Service Perspective

EE148 Are General Population Utilities Appropriate to Use as Baselines for Age-Adjustment of Utility Values?

HTA186 Accelerating Access to Medical Technologies: An Overview of the NICE Early Value Assessment Pilot Project in the UK

Immediate birth for women between 34–37 weeks’ gestation with preterm prelabour prolonged rupture of membranes and vaginal or urine GBS detection: an economic evaluation

MSR36 Modelling of UK General Population Utility: The ALDVMM Approach in Practice

MSR7 Multiplicative With Linear Transformation (MLT): An Improvement on the Multiplicative Method for Age and Sex Adjustment of Utilities?

PNS17 Adjusting General Population Utility: Preliminary Results from an Update of the Published UK Regression MODEL

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis

Cannabis-based medicinal products: summary of NICE guidance

Collaborators (1)

Gabriel Rogers

Make your next move.